1.66
Schlusskurs vom Vortag:
$1.72
Offen:
$1.77
24-Stunden-Volumen:
907.30K
Relative Volume:
0.68
Marktkapitalisierung:
$28.09M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.24M
KGV:
-2.1799
EPS:
-0.7615
Netto-Cashflow:
$-4.79M
1W Leistung:
-5.14%
1M Leistung:
+33.33%
6M Leistung:
+45.61%
1J Leistung:
-27.51%
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Firmenname
Mira Pharmaceuticals Inc
Sektor
Telefon
813-369-5150
Adresse
1200 BRICKELL AVENUE, MIAMI
Vergleichen Sie MIRA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MIRA
Mira Pharmaceuticals Inc
|
1.66 | 31.77M | 0 | -11.24M | -4.79M | -0.7615 |
![]()
LLY
Lilly Eli Co
|
762.95 | 725.47B | 49.00B | 11.11B | -1.27B | 12.29 |
![]()
JNJ
Johnson Johnson
|
168.11 | 400.31B | 90.63B | 22.66B | 16.40B | 9.35 |
![]()
ABBV
Abbvie Inc
|
191.22 | 333.00B | 57.37B | 4.20B | 15.39B | 2.35 |
![]()
NVS
Novartis Ag Adr
|
117.22 | 224.91B | 55.19B | 13.65B | 16.81B | 6.86 |
![]()
MRK
Merck Co Inc
|
82.63 | 211.08B | 63.92B | 17.43B | 17.04B | 6.87 |
Mira Pharmaceuticals Inc Aktie (MIRA) Neueste Nachrichten
MIRA Pharmaceuticals Reports Promising Preclinical Results - TipRanks
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 - Investing.com Nigeria
FDA clears MIRA’s IND application for neuropathic pain drug Ketamir-2 By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain - ACCESS Newswire
MIRA's Novel Pain Drug Shows 112% Better Relief Than Current Treatments, FDA Gives Green Light - Stock Titan
Does MIRA Pharmaceuticals Inc. stock perform well during market downturnsSmart Portfolio Recommendation For Beginners - jammulinksnews.com
MIRA Pharmaceuticals Gets FDA Clearance for Ketamir-2 Trials - TipRanks
What makes MIRA Pharmaceuticals Inc. stock price move sharplyExpert Picks Alerts For Beginners - jammulinksnews.com
How does MIRA Pharmaceuticals Inc. compare to its industry peersDiscover stocks with superior performance - jammulinksnews.com
How hedge fund analytics apply to MIRA Pharmaceuticals Inc. stockReal Time Screener for Growth Trades - Newser
Is MIRA Pharmaceuticals Inc. stock overvalued or undervaluedFree Predictions - jammulinksnews.com
What are the latest earnings results for MIRA Pharmaceuticals Inc.Discover hidden gems in the stock market - jammulinksnews.com
What is the risk reward ratio of investing in MIRA Pharmaceuticals Inc. stockExtraordinary profit generation - jammulinksnews.com
Is MIRA Pharmaceuticals Inc. Stock a Good Fit for Conservative InvestorsSafe and Scalable Investment Tips - Newser
Is it the right time to buy MIRA Pharmaceuticals Inc. stockCapitalize on fast-moving market trends - jammulinksnews.com
Why Baijiayun Group Ltd stock attracts strong analyst attentionExpert Trading Flow - Newser
Is MIRA Pharmaceuticals Inc. a Top Dividend Stock to Watch in 2025Swing Trade Signals - Newser
MIRA Pharmaceuticals Inc. Stock Analysis and ForecastFree Market Volatility Navigation Tips - PrintWeekIndia
Is MIRA Pharmaceuticals Inc. a good long term investmentBreakthrough profit margins - PrintWeekIndia
What drives MIRA Pharmaceuticals Inc. stock priceSuperior risk-adjusted returns - PrintWeekIndia
Is MIRA Pharmaceuticals Inc. stock a good hedge against inflationAccelerated earnings growth - jammulinksnews.com
What analysts say about MIRA Pharmaceuticals Inc. stockHigh-return market picks - PrintWeekIndia
Can Liberty Latin America Ltd. stock recover from recent declineSuperior returns - jammulinksnews.com
FCEL Stock Analysis and ForecastRapid market gains - jammulinksnews.com
Finanzdaten der Mira Pharmaceuticals Inc-Aktie (MIRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):